No headlines found.
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX
PRNewswire (Mon, 18-Mar 10:52 PM ET)
Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm
PRNewswire (Fri, 15-Mar 12:54 PM ET)
INVESTIGATION UPDATE: Halper Sadeh LLC Investigates IGT, AKTX, SDPI, VIVK
Globe Newswire (Sat, 9-Mar 8:54 AM ET)
Kuehn Law Encourages VIVK, HES, SDPI, and AKTX Investors to Contact Law Firm
Globe Newswire (Fri, 8-Mar 4:38 PM ET)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AKTX, HES, TGAN, NS
PRNewswire (Tue, 5-Mar 6:33 PM ET)
Business Wire (Tue, 5-Mar 11:51 AM ET)
Globe Newswire (Tue, 5-Mar 8:00 AM ET)
Globe Newswire (Tue, 2-Jan 8:00 AM ET)
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. It operates mainly in United States and United Kingdom.
Akari Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AKTX.
As of March 28, 2024, AKTX stock price climbed to $1.87 with 13,381 million shares trading.
AKTX has a market cap of $9.43 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, AKTX stock traded as high as $64.00 and as low as $1.66.
AKTX has underperformed the market in the last year with a price return of -60.3% while the SPY ETF gained +33.6%. AKTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.6% and -13.3%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
AKTX support price is $1.75 and resistance is $1.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKTX stock will trade within this expected range on the day.